Skip to content

HealthEquity HQY Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

Oscar Health logo
Oscar HealthOSCR
$1.02M+423%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's debt issuance cost amortization?
HealthEquity (HQY) reported debt issuance cost amortization of $277K in Q1 2026.
How has HealthEquity's debt issuance cost amortization changed year-over-year?
HealthEquity's debt issuance cost amortization increased by 4.5% year-over-year, from $265K to $277K.
What is the long-term trend for HealthEquity's debt issuance cost amortization?
Over 4 years (2022 to 2026), HealthEquity's debt issuance cost amortization has grown at a -29.8% compound annual growth rate (CAGR), from $4.45M to $1.08M.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).